全文获取类型
收费全文 | 187870篇 |
免费 | 1622篇 |
国内免费 | 32篇 |
专业分类
耳鼻咽喉 | 1324篇 |
儿科学 | 6926篇 |
妇产科学 | 3300篇 |
基础医学 | 18876篇 |
口腔科学 | 1671篇 |
临床医学 | 13494篇 |
内科学 | 33294篇 |
皮肤病学 | 931篇 |
神经病学 | 17389篇 |
特种医学 | 9677篇 |
外科学 | 30216篇 |
综合类 | 2430篇 |
一般理论 | 1篇 |
预防医学 | 18714篇 |
眼科学 | 3189篇 |
药学 | 10532篇 |
中国医学 | 639篇 |
肿瘤学 | 16921篇 |
出版年
2021年 | 122篇 |
2020年 | 94篇 |
2019年 | 130篇 |
2018年 | 22039篇 |
2017年 | 17467篇 |
2016年 | 19639篇 |
2015年 | 1061篇 |
2014年 | 1024篇 |
2013年 | 1104篇 |
2012年 | 7497篇 |
2011年 | 21561篇 |
2010年 | 19125篇 |
2009年 | 11836篇 |
2008年 | 19961篇 |
2007年 | 22238篇 |
2006年 | 1118篇 |
2005年 | 2730篇 |
2004年 | 3899篇 |
2003年 | 4863篇 |
2002年 | 3002篇 |
2001年 | 594篇 |
2000年 | 723篇 |
1999年 | 463篇 |
1998年 | 358篇 |
1997年 | 379篇 |
1996年 | 222篇 |
1995年 | 190篇 |
1994年 | 190篇 |
1993年 | 132篇 |
1992年 | 202篇 |
1991年 | 246篇 |
1990年 | 282篇 |
1989年 | 219篇 |
1988年 | 173篇 |
1987年 | 150篇 |
1986年 | 160篇 |
1985年 | 136篇 |
1984年 | 112篇 |
1983年 | 93篇 |
1982年 | 92篇 |
1980年 | 99篇 |
1938年 | 110篇 |
1933年 | 97篇 |
1932年 | 143篇 |
1931年 | 92篇 |
1930年 | 149篇 |
1929年 | 93篇 |
1926年 | 95篇 |
1924年 | 90篇 |
1923年 | 93篇 |
排序方式: 共有10000条查询结果,搜索用时 312 毫秒
991.
Screening for complement deficiency in bacterial meningitis 总被引:1,自引:0,他引:1
T Ernst PJ Späth C Aebi UB Schaad MG Bianchetti 《Acta paediatrica (Oslo, Norway : 1992)》1997,86(9):1009-1010
Seventy-seven children with bacterial meningitis were screened for complement deficiency. Both the classical and the alternate pathways were normal in 75 patients. Transiently reduced total haemolytic activity of the classical pathway was documented in a boy with meningococcal meningitis. Total haemolytic activity of both the classical and the alternate pathways were reduced in another patient with pneumococcal meningitis: individual complement components determination indicated predominant activation of the alternate pathway. 相似文献
992.
993.
994.
995.
Wei Yue Steven J. Santner Shigeru Masamura Ji-Ping Wang Laurence M. Demers Christopher Hamilton Richard J. Santen 《Breast cancer research and treatment》1998,49(1):S1-S7
Estradiol stimulates the growth of breast tumor cells in both pre- and post menopausal women. Following the menopause, the levels of estradiol in breast tumor tissues are similar to those from tumors obtained prior to cessation of ovarian function, even though plasma estrogen levels are 10–50 fold lower in post- than in premenopausal women. These observations suggested the possibility of enhanced estradiol uptake from plasma or in situ synthesis in post-menopausal women. We systematically studied these possibilities in a series of model systems. Initially we demonstrated a very high affinity estradiol binding site in tissues from castrated rats. Enhanced uptake occurred under conditions of low plasma estrogen levels when compared to animals with higher estradiol levels. In situ synthesis also occurred both through the sulfatase and aromatase pathways. In further studies, we compared uptake from plasma with in situ synthesis via aromatase in a nude mouse model. Under the conditions utilized, in situ synthesis resulted in much higher tissue estradiol levels and tumor growth rates than did uptake from plasma. During these studies we demonstrated that tumors deprived of estradiol developed mechanisms rendering them more sensitive to estrogen. This involved the ability of cells to adapt to estradiol deprivation to allow them to be responsive to four log lower amounts of estrogen than when studied under wild type conditions. In addition, cells adapted by increasing their level of aromatase and thus developing the capability to become more sensitive to estrogen precursors. Taken together, these studies demonstrate that breast cancer tissue is highly plastic and can adapt to conditions of estrogen deprivation via a variety of mechanisms. 相似文献
996.
997.
Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study 总被引:18,自引:0,他引:18
Mulnard RA Cotman CW Kawas C van Dyck CH Sano M Doody R Koss E Pfeiffer E Jin S Gamst A Grundman M Thomas R Thal LJ 《JAMA》2000,283(8):1007-1015
CONTEXT: Several reports from small clinical trials have suggested that estrogen replacement therapy may be useful for the treatment of Alzheimer disease (AD) in women. OBJECTIVE: To determine whether estrogen replacement therapy affects global, cognitive, or functional decline in women with mild to moderate AD. DESIGN: The Alzheimer's Disease Cooperative Study, a randomized, double-blind, placebo-controlled clinical trial conducted between October 1995 and January 1999. SETTING: Thirty-two study sites in the United States. PARTICIPANTS: A total of 120 women with mild to moderate AD and a Mini-Mental State Examination score between 12 and 28 who had had a hysterectomy. INTERVENTIONS: Participants were randomized to estrogen, 0.625 mg/d (n = 42), or 1.25 mg/d (n = 39), or to identically appearing placebo (n = 39). One subject withdrew after randomization but before receiving medication; 97 subjects completed the trial. MAIN OUTCOME MEASURES: The primary outcome measure was change on the Clinical Global Impression of Change (CGIC) 7-point scale, analyzed by intent to treat; secondary outcome measures included other global measures as well as measures of mood, specific cognitive domains (memory, attention, and language), motor function, and activities of daily living; compared by the combined estrogen groups vs the placebo group at 2, 6, 12, and 15 months of follow-up. RESULTS: The CGIC score for estrogen vs placebo was 5.1 vs 5.0 (P = .43); 80% of participants taking estrogen vs 74% of participants taking placebo worsened (P = .48). Secondary outcome measures also showed no significant differences, with the exception of the Clinical Dementia Rating Scale, which suggested worsening among patients taking estrogen (mean posttreatment change in score for estrogen, 0.5 vs 0.2 for placebo; P = .01). CONCLUSIONS: Estrogen replacement therapy for 1 year did not slow disease progression nor did it improve global, cognitive, or functional outcomes in women with mild to moderate AD. The study does not support the role of estrogen for the treatment of this disease. The potential role of estrogen in the prevention of AD, however, requires further research. 相似文献
998.
Thomsen TK, Pfeiffer P, Bertelsen K. Teniposide or carboplatin in patients with recurrent or advanced cervical carcinoma: A randomized phase II trial. Int J Gynecol Cancer 1998; 8 : 310–314.
The aim of the present study was to investigate response rates, time to progression, and survival with teniposide or carboplatin in patients with advanced or recurrent cervical cancer and to estimate the toxicity of each drug regimen.
Twenty-eight patients with recurrent or advanced cervical cancer entered the study. Two patients were ineligible (severe renal impairment, n = 1; performance status 3, n = 1) and were excluded from the analysis. The remaining 26 patients were randomized to either carboplatin (400 mg/m2 on day 1, intravenously every four weeks) or teniposide (125 mg/m2 on days 1, 2 and 3, intravenously every four weeks). Twelve patients were randomized to the carboplatin arm and 14 patients to the teniposide arm. They were all comparable with respect to age, performance status, histology, primary FIGO stage, and prior therapy.
Response was seen in four patients in each group (33% and 29%, respectively), all but one being partial. (One patient in the teniposide group had complete response). Time to progression and median survival were similar in the two groups (median time to progression 20/17 weeks and median survival 40/41 weeks, respectively.)
In general, toxicity was moderate. Leukopenia (WHO grade 3 or 4) was seen in one patient treated with teniposide, and thrombocytopenia (WHO grade 3 or 4) in one patient treated with carboplatin. Eleven patients (79%) in the teniposide group had alopecia requiring a wig. The study implies that both drugs have some activity in cervical cancer. Carboplatin has the advantage that it can be administered on an out-patient basis. 相似文献
The aim of the present study was to investigate response rates, time to progression, and survival with teniposide or carboplatin in patients with advanced or recurrent cervical cancer and to estimate the toxicity of each drug regimen.
Twenty-eight patients with recurrent or advanced cervical cancer entered the study. Two patients were ineligible (severe renal impairment, n = 1; performance status 3, n = 1) and were excluded from the analysis. The remaining 26 patients were randomized to either carboplatin (400 mg/m
Response was seen in four patients in each group (33% and 29%, respectively), all but one being partial. (One patient in the teniposide group had complete response). Time to progression and median survival were similar in the two groups (median time to progression 20/17 weeks and median survival 40/41 weeks, respectively.)
In general, toxicity was moderate. Leukopenia (WHO grade 3 or 4) was seen in one patient treated with teniposide, and thrombocytopenia (WHO grade 3 or 4) in one patient treated with carboplatin. Eleven patients (79%) in the teniposide group had alopecia requiring a wig. The study implies that both drugs have some activity in cervical cancer. Carboplatin has the advantage that it can be administered on an out-patient basis. 相似文献
999.
Smoking practices in New York City: The use of a population-based survey to guide policy-making and programming 总被引:4,自引:0,他引:4
Farzad Mostashari Bonnie D. Kerker Anjum Hajat Nancy Miller Thomas R. Frieden 《Journal of urban health》2005,82(1):58-70
To inform New York City’s (NYC’s) tobacco control program, we identified the neighborhoods with the highest smoking rates,
estimated the burden of second-band smoke exposure, assessed the early response to state taxation, and examined cessation
practices. We used a stratified random design to conduct a digit-dialed telephone survey in 2002 among 9,674 New York City
adults. Our main outcome measures included prevalence of cigarette smoking, exposure to second-hand smoke, the response of
smokers to state tax increases, and cessation practices. Even after controlling for sociodemographic factors (age, racelethnicity,
income, education, marital status, employment status, and foreign-born status) smoking rates were highest in Central Harlem
and in the South Bronx. Sixteen percent of nonsmokers reported frequent exposure to second-hand smoke at home or in a workplace.
Among smokers with a child with asthma, only 33% reported having a no-smoking policy in their homes. More than one fifth of
smokers reported reducing the number of cigarettes they smoked in response to the state tax increase. Of current smokers who
tried to quit, 65% used no cessation aid. These data were used to inform New York City’s smoke-free legislation, taxation,
public education, and a free nicotine patch give-away program. In conclusion, large, local surveys can provide essential data
to effectively advocate for, plan, implement, and evaluate a comprehensive tobacco control program.
Dr. Mostashari (the guarantor) made substantial contributions to the conception, design, and supervision of this paper, the
analysis and interpretation of data, the drafting of the paper, critical revisions of the paper for important intellectual
content, and the acquisition of data and funding for this research. Dr. Kerker made substantial contributions to the analysis
and interpretation of data, the drafting of the paper and critical revisions of the paper for important intellectual content.
Ms. Hajat made substantial contributions to the acquisition of data and critical revisions of the paper for important intellectual
content. Dr. Miller made substantial contributions to the conception of this paper and critical revisions of the paper for
important intellectual content. Dr. Frieden made substantial contributions to the conception, design, and supervision of this
paper and critical revisions of the paper for important intellectual content. 相似文献
1000.
Viroj Wiwanitkit 《Sexuality and disability》2005,23(1):41-46
The incidence of sexual assault continues to escalate, and it is under-reported. Recent literature discusses the medical, legal, and psychological management of the female sexual assault victim, but little has been written regarding appropriate management of male sexual assault. This article focuses on the laboratory investigation in male rape case. 相似文献